Vaxcyte Inc.

NASDAQ: PCVX
Share price (3/25/25): $71.90
Market cap (3/25/25): $9.258 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Automatic shelf registration

Registration of securities for employees

Ownership Filter

Eydelman Mikhail

Eydelman Mikhail

Guggenhime Andrew

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Material Definitive Agreement, Other Events

Reports Third Quarter 2024 Financial Results and Provides Business Update

Other Events, Financial Statements or Exhibits

Reports Positive Topline Data From Phase 1/2 Study of VAX-31, Its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC